Skip to content
Screener

Becton, Dickinson and Company BDX Q3 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$5.0BBeat by $95.9M
Adjusted EPS$3.23Beat by $0.09
Revenue estimate$4.9B
EPS estimate$3.14
“We delivered a strong third quarter, with revenue, adjusted operating margin and adjusted EPS all ahead of our expectations. Our first full quarter as New BD demonstrates the early benefits of a more focused MedTech company, with strong momentum across our key growth platforms, continued innovation and further progress through BD Excellence. We remain focused on disciplined execution, advancing our key growth platforms, expanding margins and allocating capital strategically to drive sustainable growth and long-term shareholder value.”
Tom Polen

Earnings data and commentary were extracted with AI from company filings and may contain errors. Verify important details in the filing.

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$5.1B
EPS estimate$4.06

Financials

Q3 2026

Income statement

See full
Revenue$5.0B-9.5%
Gross profit$2.3B-12.1%
Operating income$663.0M-24.8%
Net income$377.0M-34.3%
EPS (diluted)$1.64-18.0%

Balance sheet

See full
Cash & equivalents$708.0M-11.3%
Total debt$13.5B-22.9%
Total equity$24.4B-4.1%
Total assets$50.7B-7.6%

Cash flow

See full
Operating cash flow$776.0M-51.1%
CapEx$143.0M-24.3%
Free cash flow$633.0M-54.7%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$51.81B-7.5%
Enterprise value$64.61B-11.2%
P/E55.1×+19.7×
P/S2.5×-0.2×

Profitability

See full
Gross margin46.4%+1.7pp
Operating margin9.6%-1.7pp
Net margin4.5%-3.2pp
FCF margin13.1%—

Returns & leverage

See full
Return on equity3.8%-2.4pp
Debt / equity0.6×-0.1×

Segments

By segment

See full
Medical Essentials$1.7B—
Interventional$1.4B+6.5%
Connected Care$1.2B—
BioPharma Systems$670.0M—

FAQ

When did Becton, Dickinson and Company report Q3 2026 earnings?
Becton, Dickinson and Company (BDX) reported Q3 2026 earnings on August 6, 2026 before market open.
What were Becton, Dickinson and Company's Q3 2026 revenue and EPS?
Becton, Dickinson and Company reported revenue of $5.0B and adjusted eps of $3.23 for Q3 2026.
Did Becton, Dickinson and Company beat estimates in Q3 2026?
Revenue beat the consensus estimate of $4.9B by $95.9M. EPS beat the consensus estimate of $3.14 by $0.09.
How did Becton, Dickinson and Company's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.5% from $5.5B a year earlier.
Where can I find Becton, Dickinson and Company's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-053790) and the 10-Q periodic report (0000010795-26-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.